Cyclin D1-CDK4/6 complexes play a central role in promoting G1-S-phase transition in ER+ breast cancer [16], and p21 inactivated the cyclin D1-CDK4/6 complexes to block the G1-S transition by directly binding to the complexes [17]. Here, CDK4 is linked to breast carcinoma.